Novel cancer drug reduces neuroblastoma growth by 75 percent

Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have found a new drug that restricts the growth of neuroblastoma, a childhood brain cancer. The pre-clinical study was presented today in the plenary session at the 22nd annual meeting of the American Society of Pediatric Hematology/Oncology.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news159728519.html">Novel cancer drug reduces neuroblastoma growth by 75 percent</a></p> <p>Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have found a new drug that restricts the growth of neuroblastoma, a childhood brain cancer. The pre-clinical study was presented today in the plenary session at the 22nd annual meeting of the American Society of Pediatric Hematology/Oncology.</p>